4.6 Article

DNA Methylation Signatures and the Contribution of Age-Associated Methylomic Drift to Carcinogenesis in Early-Onset Colorectal Cancer

期刊

CANCERS
卷 13, 期 11, 页码 -

出版社

MDPI
DOI: 10.3390/cancers13112589

关键词

early onset colorectal cancer; colorectal cancer; DNA methylation; age acceleration; epigenetic drift

类别

资金

  1. VicHealth
  2. Australian National Health, and Medical Research Council [209057, 396414, 1074383]
  3. National Cancer Institute of the National Institutes of Health [U01CA167551]
  4. Victorian Cancer Registry, Australia
  5. NHMRC R.D. Wright Career Development Fellowship
  6. NHMRC Emerging Leadership Investigator grant
  7. University of Melbourne Research at Melbourne Accelerator Program (R@MAP)
  8. Australian Government Research Training Program Scholarship
  9. Australasian Colorectal Cancer Family Registry [NCI/NIH U01 CA074778, U01/U24 CA097735]
  10. CCFR [C-AU-0312-01]
  11. Cancer Council Victoria

向作者/读者索取更多资源

This study identified unique DNA methylation changes in early-onset colorectal cancer (EOCRC) at 234 loci. CpGs associated with ageing-related methylation drift were significantly altered in EOCRC, with evidence of accelerated ageing in normal mucosa. The findings suggest that EOCRC acquires distinct DNAm alterations, contributing to its earlier onset compared to intermediate- and late-onset CRC.
Simple Summary The role of DNA methylation in the carcinogenesis of colorectal cancer (CRC) diagnosed <50 years of age (early-onset CRC or EOCRC) is currently unknown. In this study, we investigated the genome-wide DNA methylation of 97 tumour and 54 normal colonic mucosa samples from people with EOCRC with the aim of identifying unique DNA methylation signatures and determining the role of ageing-related DNA methylation drift and age-acceleration in EOCRC aetiology. We found extensive DNA methylation alterations associated with EOCRC carcinogenesis, including a unique signature comprising 234 loci compared with CRCs from people >50 years of age. CpGs that undergo ageing-related methylation drift were significantly altered in EOCRC, and accelerated ageing was also evident in normal mucosa from people with EOCRC. Our study is the first study to identify unique DNA methylation changes in EOCRC, contributing novel information that may aid future efforts towards EOCRC prevention. We investigated aberrant DNA methylation (DNAm) changes and the contribution of ageing-associated methylomic drift and age acceleration to early-onset colorectal cancer (EOCRC) carcinogenesis. Genome-wide DNAm profiling using the Infinium HM450K on 97 EOCRC tumour and 54 normal colonic mucosa samples was compared with: (1) intermediate-onset CRC (IOCRC; diagnosed between 50-70 years; 343 tumour and 35 normal); and (2) late-onset CRC (LOCRC; >70 years; 318 tumour and 40 normal). CpGs associated with age-related methylation drift were identified using a public dataset of 231 normal mucosa samples from people without CRC. DNAm-age was estimated using epiTOC2. Common to all three age-of-onset groups, 88,385 (20% of all CpGs) CpGs were differentially methylated between tumour and normal mucosa. We identified 234 differentially methylated genes that were unique to the EOCRC group; 13 of these DMRs/genes were replicated in EOCRC compared with LOCRCs from TCGA. In normal mucosa from people without CRC, we identified 28,154 CpGs that undergo ageing-related DNAm drift, and of those, 65% were aberrantly methylated in EOCRC tumours. Based on the mitotic-based DNAm clock epiTOC2, we identified age acceleration in normal mucosa of people with EOCRC compared with normal mucosa from the IOCRC, LOCRC groups (p = 3.7 x 10(-16)) and young people without CRC (p = 5.8 x 10(-6)). EOCRC acquires unique DNAm alterations at 234 loci. CpGs associated with ageing-associated drift were widely affected in EOCRC without needing the decades-long accrual of DNAm drift as commonly seen in intermediate- and late-onset CRCs. Accelerated ageing in normal mucosa from people with EOCRC potentially underlies the earlier age of diagnosis in CRC carcinogenesis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据